Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 4/29/21 → 6/7/25 |
Funding
- Exelixis Inc.: $193,467.00
Phase II Clinical Trial Evaluating Cabozantinib and Pembrolizumab in Metastatic Pancreatic Cancer
- Kim, Joseph (PI)
| Status | Active |
|---|---|
| Effective start/end date | 4/29/21 → 6/7/25 |